Literature DB >> 24122271

The elevated pre-operative plasma fibrinogen level is an independent negative prognostic factor for cancer-specific, disease-free and overall survival in soft-tissue sarcoma patients.

Joanna Szkandera1, Martin Pichler, Bernadette Liegl-Atzwanger, Gudrun Absenger, Michael Stotz, Ferdinand Ploner, Tatjana Stojakovic, Hellmut Samonigg, Katharina Eberhard, Andreas Leithner, Armin Gerger.   

Abstract

BACKGROUND AND OBJECTIVES: Accumulating evidence indicates an important pathophysiological role of fibrinogen on tumor cell progression and metastases in different types of cancer. The aim of the present study was to evaluate the prognostic relevance of pre-operative fibrinogen levels on clinical outcome in a large cohort of STS patients.
METHODS: Two hundred ninety-four consecutive STS patients were retrospectively evaluated. Cancer-specific survival (CSS), disease-free survival (DFS), and overall survival (OS) were assessed using the Kaplan-Meier curves and Cox regression models. Finally, we supplemented the well-established Kattan nomogram by the fibrinogen level and evaluated the gain of predictive accuracy of this novel nomogram by Harrell's concordance index (c-index).
RESULTS: An elevated plasma fibrinogen level was significantly associated with established prognostic factors, including age, tumor grade, size, and depth (P<0.05). Furthermore, in multivariate analysis, increased fibrinogen levels were significantly associated with a poor outcome for CSS (HR=2.48; 95% CI=1.28-4.78; P=0.007), DFS (HR=2.00; 95% CI=1.11-3.60; P=0.021), and OS (HR=2.20; 95% CI=1.39-3.47; P<0.001). The estimated c-index was 0.747 using the original Kattan nomogram and 0.779 when the fibrinogen levels was added.
CONCLUSION: The pre-operative plasma fibrinogen level may represent a strong and independent unfavorable prognostic factor for CSS, DFS and OS in STS patients.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  plasma fibrinogen level; prognostic factor; soft-tissue sarcoma

Mesh:

Substances:

Year:  2014        PMID: 24122271     DOI: 10.1002/jso.23458

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  4 in total

1.  Pre-treatment neutrophil-to-lymphocyte ratio predicts prognosis in patients with locoregionally advanced laryngeal carcinoma treated with chemoradiotherapy.

Authors:  Yue-Can Zeng; Feng Chi; Rui Xing; Ming Xue; Li-Na Wu; Mei-Yue Tang; Rong Wu
Journal:  Jpn J Clin Oncol       Date:  2015-11-25       Impact factor: 3.019

2.  Predictive Value of Preoperative Controlling Nutritional Status Score Combined with Fibrinogen-Albumin Ratio in Postoperative Local Recurrence-Free Survival of Patients with Retroperitoneal Liposarcoma.

Authors:  Guo-Qiang Xue; Cheng-Peng Li; Ang Lv; Xiu-Yun Tian; Jian-Hui Wu; Hui Qiu; Chun-Yi Hao
Journal:  Cancer Manag Res       Date:  2021-08-06       Impact factor: 3.989

3.  Prognostic role of plasma fibrinogen in patients with uterine leiomyosarcoma - a multicenter study.

Authors:  Christine Bekos; Christoph Grimm; Thomas Brodowicz; Edgar Petru; Lukas Hefler; Daniel Reimer; Horst Koch; Alexander Reinthaller; Stephan Polterauer; Mariella Polterauer
Journal:  Sci Rep       Date:  2017-11-03       Impact factor: 4.379

4.  Prognostic value of the fibrinogen/albumin ratio (FAR) in patients with operable soft tissue sarcoma.

Authors:  Yao Liang; Wei Wang; Yi Que; Yuanxiang Guan; Wei Xiao; Cheng Fang; Xing Zhang; Zhiwei Zhou
Journal:  BMC Cancer       Date:  2018-10-03       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.